1.Warren, JW. Catheter-associated urinary tract infection. Infect Dis Clin North Am 1987;1:823–854.
2.Kass, EH, Schneiderman, LJ. Entry of bacteria into the urinary tract of patients with inlying catheters. N Engl J Med 1957;256:556–557.
3.Garibaldi, RA, Burke, JP, Dickman, ML, Smith, CB. Factors predisposing to bacteriuria during indwelling urethral catheters. N Engl J Med 1974;291:215–219.
4.Kunin, CM, McCormack, RC. Prevention of catheter-induced urinary tract infections by sterile closed drainage. N Engl J Med 1966;274:1155–1161.
5.Garibaldi, RA, Burke, JP, Britt, MR, Miller, WA, Smith, CB. Meatal colonization and catheter-associated bacteriuria. N Engl J Med 1980;303:316–318.
6.Tambyah, PA, Halvorson, KT, Maki, DG. A prospective study of pathogenesis of catheter-associated urinary tract infections. Mayo Clin Proc 1999;74:131–136.
7.Butler, HK, Kunin, CM. Evaluation of polymyxin catheter lubricant and impregnated catheters. J Urol 1968;100:560–566.
8.Burke, JP, Garibaldi, RA, Britt, MR, Jacobson, JA, Conti, M, Ailing, DW. Prevention of catheter-associated urinary tract infection: efficacy of daily meatal care regimens. Am J Med 1981;70:655–658.
9.Webster, J, Hood, RH, Burridge, CA, Doidge, M, Phillips, M, George, N. Water or antiseptic for periurethral cleaning before urinary catheterization: a randomized controlled trial. Am J Infect Control 2001;29:389–394.
10.Leidberg, H, Lundeberg, T. Silver alloy coated catheters reduce catheter-associated bacteriuria. Br J Urol 1990;65:379–381.
11.Johnson, JR, Berggren, , Conway, AJ. Activity of nitrofurazone matrix catheter against catheter-associated uropathogens. Antimicrob Agents Chemother 1993;37:2033–2036.
12.Johnson, JR, Roberts, PL, Olsen, R, Moyer, K, Stamm, WE. Prevention of catheter-associated urinary tract infections with silver oxide-coated urinary catheter: clinical and microbiological correlates. J Infect Dis 1990;162:1145–1150.
13.Riley, DK, Classen, DC, Stevens, E, Burke, JP. A large randomized clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. Am J Med 1995;98:349–356.
14.Thibon, P, Coutour, XL, Leroyer, R, Fabry, J. Randomized multi-centre trial of the effect of catheter coated with hydrogel and silver salts on the incidence of hospital-acquired urinary infections. J Hosp Infect 2000;45:117–124.
15.Johnson, JR, Delavari, P, Azar, M. Activities of a nitrofurazone-containing urinary catheter and a silver hydrogel catheter against multidrug-resistant bacteria characteristic of catheter-associated urinary tract infection. Antimicrob Agents Chemother 1999;43:2990–2995.
16.Maki, DG, Knasinski, V, Halvorson, KT, Tambyah, PA, Holcomb, RG. A prospective, randomized, investigator-blinded trial of a novel nitrofura-zone-impregnated urinary catheter. Infect Control Hosp Epidemiol 1997;18(suppl):50. Abstract.
17.Tambe, SM, Sampath, L, Modak, SM. In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices. J Antimicrob Chemother 2001;47:589–598.
18.Modak, SM, Sampath, L. Development and evaluation of a new polyurethane central venous antiseptic catheter: reducing central venous catheter infections. Complications in Surgery 1992;11:23–29.
19.Bach, A. Clinical studies on the use of antibiotics and antiseptic bonded catheters to prevent catheter related infection. International Journal of Medical Microbiology, Virology, and Parasitology 1995;283:208–214.
20.Collin, GR. Decreasing catheter colonization through use of an antiseptic-impregnated catheter: a continuous quality improvement project. Chest 1999;115:1632–1640.
21.Maki, DG, Stolz, SM, Wheeler, S, Mermel, LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized controlled trial. Ann Intern Med 1997;127:257–266.
22.Dent, L, Modak, SM, Sampath, L, Oluwole, SF, Hardy, MA. Evaluation of an infection-resistant silver-chlorhexidine-impregnated PTFE soft tissue patch. Surgical Forum 1992;43:70–72.
23.Kim, CY, Kumar, A, Sampath, L, Sokol, DVM, Modak, SM. Evaluation of an antimicrobial-impregnated continuous ambulatory peritoneal dialysis catheter for infection control in rats. Am J Kidney Dis 2002;39:165–173.
24.Modak, SM, Fox, CL Jr. Binding of silver sulfadiazine to the cellular components of Pseudomonas aeruginosa. Biochem Pharmacol 1973;22:2391–2404.
25.Sampath, LA, Choudhury, N, Caraos, L, Modak, SM. Infection resistance of surface modified catheterization with either short-lived or prolonged activity. J Hosp Infect 1995;30:201–210.
26.Bratton, AC, Marshall, EK. A new coupling component for sulphonamide determination. J Biol Chem 1939;128:537–550.
27.Russell, AD. Chlorhexidine: antibacterial action and bacterial resistance. Infection 1986;14:212–215.
28.Hugo, WB. Disinfection mechanisms. In: Russell, AD, Hugo, WB, Ayliffe, GAJ, eds. Principles and Practice of Disinfection, Preservation and Sterilization. Oxford: Blackwell Scientific Publication; 1982:158–185.
29.Meincke, BE, Kranz, RG, Lynch, DL. Effect of irgasan on bacterial growth and adsorption into the cell wall. Microbios 1980;28:133–147.
30.Sastzu, M, Shimizu, K, Noguchi, N, Kono, M. Triclosan-resistant Staphylococcus aureus. Lancet 1993;341:756.
31.McMurry, LM, Oethinger, M, Levy, SB. Triclosan targets lipid synthesis. Nature 1998;394:531–532.
32.Denton, GW. Chlorhexidine. In: Block, SS, ed. Disinfection, Sterilization and Preservation, 4th ed. Philadelphia: Lea and Febiger; 1991:274–289.
33.Modak, SH, Fox, CL. Synergistic action of silver sulfadiazine and sodium piperacillin on resistant Pseudomonas aeruginosa in vitro and in experimental burn wound infections. J Trauma 1985;25:27–31.
34.Whalen, RL, Cai, C, Thompson, LM, Sarrasin, MJ, Dempsey, DJ, Bowen, MA. An infection inhibiting urinary catheter material. ASAIO J 1997;43:M842–M847.
35.Greenfeld, JI, Sampath, L, Popilskis, SJ, Brunnert, SR, Stylianos, S, Modak, S. Decreased bacterial adherence and biofilm formation on chlorhexidine and silver sulfadiazine-impregnated central venous catheters implanted in swine. Crit Care Med 1995;23:894–900.
36.Sampath, L, Sabrio, DV, Yaron, I, Modak, S. Safety and efficacy of an improved antiseptic catheter impregnated intraluminally with chlorhexidine. Journal of Infusion Nursing 2001;24:395–403.
37.Bhargava, HN, Leonard, PA. Triclosan: applications and safety. Am J Infect Control 1996;24:209–218.
38.Desalva, SJ, Kong, BM, Lin, YJ. Triclosan: a safety profile. American Journal of Dentistry 1989;2:185–196.
39.Saint, S, Elmore, JG, Sullivan, SD, Emerson, SS, Koepsell, TD. The efficacy of silver alloy-coated urinary catheter in preventing urinary tract infection: a meta-analysis. Am J Med 1998;105:236–241.
40.Maki, DG, Knasinski, V, Halvorson, K, Tambyah, PA. A novel silver-hydrogel impregnated indwelling urinary catheter reduces catheter-associated urinary tract infections: a prospective double-blind trial. Infect Control Hosp Epidemiol 1998;19:682.
41.Darouiche, RO, Safar, H, Raad, II. In vitro efficacy of antimicrobial-coated bladder catheters in inhibiting bacterial migration along catheter surface. J Infect Dis 1997;176:1109–1112.